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Prevalence and Natural History
of Neuropsychiatric Syndromes in Veteran
Hospice Patients
Elizabeth R. Goy, PhD, and Linda Ganzini, MD, MPH
Mental Health Division and Health Services Research and Development Program, Portland Veterans
Affairs Medical Center; and the Department of Psychiatry, Oregon Health and Science University,
Portland, Oregon, USA

Abstract
Context. Prospective studies are needed to adequately describe the overall
impact of neuropsychiatric syndromes on the course of hospice enrollment in
outpatient settings.
Objectives. To determine the prevalence and natural history of delirium,
cognitive impairment, alcohol abuse, anxiety, depression, and suicidal ideation
(SI) in community-dwelling veteran hospice patients.
Methods. Home hospice patients were visited regularly from enrollment until
their deaths, study withdrawal, or discharge from hospice. Family caregivers gave
consent for those with Mini-Mental State Examination (MMSE) scores less than or
equal to 23. Measures included the Structured Clinical Interview for DSM-IV for
depression (past and current) and alcohol abuse; the Hospital Anxiety and
Depression Scale; MMSE; and Confusion Assessment Method (CAM). A clinicianrated CAM item documented sleep disturbance, and participants were asked
about SI at each visit.
Results. The median length of hospice enrollment was 81 days. Of 88
participants, 77 (88%) experienced at least one neuropsychiatric syndrome.
Cognitive impairment was prevalent, with 60 (68%) registering MMSE less than or
equal to 23 at least once. More than half of the participants developed delirium;
the proportion with delirium, any cognitive impairment, sleep disturbance, or any
neuropsychiatric syndrome increased significantly from first to last study visit.
Twelve (14%) participants had SI during the study, and 30 (34%) participants
were affected by depression overall. Sixteen patients who were not depressed on
admission subsequently developed depression. Anxiety was present in 14 (16%)
on at least one study visit. Active alcohol abuse remained relatively stable (8%)
across visits.
Conclusions. Psychiatric syndromes are highly prevalent in hospice patients.
Systematic case finding of psychiatric disorders may be necessary to improve
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Introduction

Methods

The passage through the final months of life
is marked by accumulating physical challenges
that can be complicated by distressing mental
disorders, including depression, anxiety, delirium, alcohol abuse, sleep disturbance, and cognitive impairment. Although the hospice
treatment model is ideally guided by a holistic
biopsychosocial approach, studies have repeatedly shown that health care providers tend to
underrecognize or undertreat both depression
and delirium in their hospice patients, and
very little is known about the prevalence and
course of substance abuse, anxiety, and sleep
difficulties in this setting.1 Documentation of
the incidence, prevalence, and natural history
of neuropsychiatric syndromes during hospice
enrollment is essential to alert care providers
to the full range of palliative needs of
community-dwelling hospice patients.
In the United States, most hospice treatment is provided outside of medical settings,
with at least two-thirds of hospice patient
deaths occurring at home.2 The prevalence
of individual neuropsychiatric syndromes,
however, has been examined rigorously in inpatient cancer palliative care units, mostly outside of the United States.1,3e9 These samples
may not be representative of community
hospice if only patients with particularly difficult management problems or poor social
support are admitted. Studies of outpatient,
community-dwelling palliative care, and hospice populations have shed some light on specific mental disorders; however, much of the
research is either retrospective or crosssectional.10 Prospective studies are needed to
adequately describe the overall impact of neuropsychiatric syndromes on the course of hospice enrollment in outpatient settings. The
goal of this study was to determine the prevalence, severity, and natural history of neuropsychiatric syndromes in terminally ill veterans
enrolled in community hospice.

The protocol and recruitment methods
were approved by the Portland Veterans Affairs
Medical Center (PVAMC) Institutional Review
Board. This longitudinal study used repeated
in-home visits by the study psychologist or psychology doctoral candidates trained by the psychologist. Eligible participants were veterans
who had been referred for hospice care and
survived long enough to be contacted by the
study (within two weeks of study referral), lived
within a 50-mile radius of the PVAMC, and had
speech and hearing adequate to complete
a structured clinical interview. Participants
who were approved for study participation by
their primary care provider at the PVAMC
were recruited by mail and follow-up telephone call. Those enrolled were seen an average of six days after referral to hospice, for
three weekly visits and then every other week
continuing until their deaths, withdrawal
from the study, or discharge from hospice because of improved medical or functional status. Data were analyzed from participants
who were evaluated within 90 days of death.
All participants with Mini-Mental State Examination (MMSE) score greater than 23 gave
written informed consent; those with scores
less than or equal to 23 were consented by
proxy through their primary caregivers, usually
a family member, and additionally gave their
assent to participate.

Measures
Measures were chosen to determine the
prevalence and incidence of mental disorders
and, more broadly, neuropsychiatric syndromes, including alcohol abuse; suicidal ideation (SI); and the prevalence and severity of
depression, delirium, anxiety, sleep disturbance, and cognitive impairment. We obtained
demographic information through interview
and electronic medical record review, including the participant’s age, sex, educational
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attainment, race, marital status, past psychiatric diagnoses from the medical record, and
medical reason for hospice referral. Confusion, cognitive impairment, and delirium
were assessed using 1) the MMSE, with a cutoff
of 23 or lower out of 30 possible points, indicating possible delirium or dementia, and 2)
the observer-rated Confusion Assessment
Method (CAM). The CAM documents the
presence or absence of hallmark symptoms of
delirium (e.g., inattention, disorientation,
sleep disturbance) and results in a positive
score for delirium if both acute onset and inattention are observed and either disorganized
thinking or altered level of consciousness is
present. The clinician-rated CAM item, ‘‘presence or absence of sleep disturbance,’’ was
based on direct observation and patient/caregiver report and used to calculate point prevalence of sleep disturbance. In all subjects, we
also rated the presence or absence of SI by asking,11,12 ‘‘During the past week/two weeks,
were things so bad that you were thinking
that you would be better off dead, or thinking
a lot about harming yourself?’’
Additional measures were completed in participants whose CAM was negative and MMSE
greater than 23. A one-time Structured Clinical
Interview for DSM-IV (SCID) was conducted at
the first visit to document history of past
depression and alcohol abuse/dependence.
The SCID interview for current depression
and current alcohol abuse was then administered at each subsequent visit. The severity of
depression and anxiety also was assessed with
the 14-item Hospital Anxiety and Depression
Scale (HADS), where each item score ranged
from 0 ¼ none to 3 ¼ severe. Anxiety and depression severity scores each ranged from
0 to 21. Subjects were categorized as depressed
if either the SCID or the HADS (using a cutpoint of 11 or higher) met the criteria for
depression for two or more weeks. A HADS
anxiety score of 10 or higher was used to
identify presence of anxiety.

Statistical Analysis
Demographic variables are represented as
frequencies and proportions. Continuous variables are described by means if normally
distributed or by medians for skewed data.
We report demographic characteristics and
whether participants ever endorsed SI for the
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full sample of eligible participants. We excluded those whose last study visit occurred
more than 90 days before the date of death
when determining the presence of a disorder
at first visit, last visit, or whether a disorder
was ever present during the course of the
study. Anxiety, depression, and alcohol dependence were recorded as not present on study
visits when patients were delirious. Categorical
data were evaluated using the Chi-squared statistic, and means with standard deviations
(SDs) were compared with Student’s t-test.
McNemar’s statistic for within-subjects comparisons was used to test whether there were
differences between two study visits (e.g., first
and last).

Results
Study Demographics
Of 795 veterans referred to hospice care,
467 were not eligible to participated270
were referred to out-of-range facilities, 153
died within two weeks of hospice referral, 32
declined hospice, and 12 were not eligible
for other reasons. Of the 328 eligible subjects,
we enrolled 106 subjects. Those not enrolled
included 41 whose physicians did not approve
their participation, 107 who declined participation for themselves, and 74 who could not
be contacted. Excluding two survivors at the
close of the study and one person whose consent form was incomplete, we analyzed 103
hospice patient participants. The study participants (n ¼ 103) were comparable to the eligible nonparticipants (n ¼ 222) with respect to
demographic and diagnostic characteristics,
except for the mean survival span from referral
to death (186 days for the participants and 115
days for the nonparticipants, t ¼ 2.8,
P ¼ 0.005). Fifteen participants eventually
withdrew from the study because of fatigue
(n ¼ 1), discharge from hospice (n ¼ 13), or
loss to further follow-up (n ¼ 1); all 15 died
over 90 days later. These veterans are not included in some analyses.
The 103 veterans studied were predominantly male and Caucasian (Table 1), reflecting the demographics of the PVAMC. The
participants ranged in age from 45 to 93 years
and had completed a mean of 12.6 years of education. About half were married (Table 1).
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Table 1
Personal and Clinical Characteristics of Study Subjects at Entry to Hospice Care (n ¼ 103)
Personal Characteristics

n

%

Sex
Male
Female

97
6

94.2
5.8

Race
White
Black
Asian

96
5
2

93.2
4.9
1.9

Marital status
Married
Not married
Unknown

51
49
3

49.5
47.6
2.9

66
18
3
6
3
1
6
56
41

64.1
17.5
2.9
5.8
2.9
1.0
5.8
54.4
41.4

Diagnosis for hospice referral
Cancer
Cardiopulmonary disease
End-stage kidney disease
End-stage liver disease
Neurological disease (stroke)
Amyotrophic lateral sclerosis
Dementia
Any past history of psychiatric diagnoses
Past depression by medical record or structured
clinical interview for DSM-IV (n ¼ 99)
Past alcohol abuse (n ¼ 100)
History of dementia by medical record diagnosis
Age in years, mean (SD)
Education in years, mean (SD, n ¼ 93)
Median (IQR) length of hospice care in daysa

45
21
70 (11.8)
12.6 (2.7)
81 (43e157)

45.0
20.4

DSM-IV ¼ Diagnostic and Statistical Manual of Mental Disorders, fourth edition; IQR ¼ interquartile range.
a
Includes 88 participants under hospice care within 90 days of the date of death; the 15 patients whose last study visit was more than 90 days before
death were excluded from this analysis.

The most common terminal diagnosis was cancer. For those 88 veterans who remained in the
study from enrollment to within 90 days of the
date of death, the median length of hospice
care received was 81 days, with 32 (36%) receiving less than two months of hospice care.

below this threshold at least once during the
study. More than half developed frank delirium and/or sleep disturbance. Comparison
Table 2
Prevalence of Neuropsychiatric Syndromes at
Any Time During Hospice Care (n ¼ 88)
Disorder

Mental Disorders Before Hospice Enrollment
Medical record review and historical interviewing with the SCID revealed that more
than half of the 103 participants had a past history of Axis I psychiatric diagnoses, including
major depressive disorder in 41%, alcohol
abuse/dependence in 45%, and/or a medical
record diagnosis of dementia in 20% (Table 1).

Cognitive Impairment, Sleep Disturbance,
and Delirium
Seventy-seven (88%) participants were diagnosed with at least one neuropsychiatric syndrome during study enrollment (Table 2).
Cognitive impairment, identified by MMSE
score less than or equal to 23, was the most
common problem, with 68% falling at or

n(%)
a,b

Depression
Alcohol dependencea,c
Cognitive impairmentd
Deliriume
Sleep disturbancef
Anxietya,g
Suicidal ideationh
Any of the aforementioned syndromes

30
9
60
48
47
14
12
77

(34.1)
(10.2)
(68.2)
(54.5)
(53.4)
(15.9)
(13.6)
(87.5)

Analysis restricted to patients enrolled in hospice, evaluated within
90 days of death.
a
Coded as not present when patient was delirious (CAM).
b
Either positive on SCID or HADS depression score $ 11.
c
SCID screening question for current alcohol abuse.
d
MMSE score # 23.
e
Based on CAM algorithm: Must have both acute onset with fluctuating course and inattention, plus either disorganized thinking or
altered level of consciousness.
f
Based on yes/no CAM item: ‘‘Did the patient have evidence of disturbance of the sleep-wake cycle, such as excessive daytime sleepiness with insomnia at night?’’
g
HADS anxiety score $ 10.
h
Based on SCID item ‘‘During the past week/two weeks, were
things so bad that you were thinking that you would be better
off dead, or thinking a lot about harming yourself?’’
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Table 3
Prevalence of Neuropsychiatric Syndromes at First and Last Study Visits (n ¼ 73)
At First Visit

At Last Visit

n(%)

n(%)

Disorder
a,b

Depression
Alcohol dependencea,c
Cognitive impairmentd
Deliriume
Sleep disturbancef
Anxietya,g
Suicidal ideationh
Any of the aforementioned syndromes

14
7
25
3
14
5
3
42

(19.2)
(9.6)
(34.2)
(4.1)
(19.2)
(6.8)
(4.1)
(57.5)

11
5
36
31
28
2
1
58

P-value

(15.1)
(6.8)
(49.3)
(42.5)
(38.4)
(2.7)
(1.4)
(79.5)

0.61
0.62
0.03
<0.01
0.01
0.19
0.62
<0.01

Analysis restricted to patient enrolled in hospice care within 90 days of death, who had at least two study visits. Compared with McNemar’s Test.
a
Coded as not present when patient was delirious (CAM) is positive.
b
Either positive on SCID or HADS depression score $ 11.
c
SCID screening question for current alcohol abuse.
d
MMSE score # 23.
e
Based on CAM algorithm: must have both acute onset with fluctuating course and inattention, plus either disorganized thinking or altered level of
consciousness.
f
Based on yes/no CAM item: ‘‘Did the patient have evidence of disturbance of the sleep-wake cycle, such as excessive daytime sleepiness with
insomnia at night?’’
g
HADS anxiety score $ 10.
h
Based on SCID item ‘‘During the past week/two weeks, were things so bad that you were thinking that you would be better off dead, or thinking
a lot about harming yourself?’’

of point prevalence at first and last study visits
revealed that sleep disturbance, cognitive impairment, and delirium increased significantly
in the final weeks of life compared with those
at entry (Table 3).

participants who expressed SI also were clinically anxious (Table 4). For the eight with SI
who also completed the HADS on the same
date, the average anxiety score was 11.4
(SD ¼ 4.7), whereas the average depression
score was 11.1 (SD ¼ 5.1).

Depression
Of the 34 subjects with pre-existing major
depressive disorder who were assessed within
90 days of death, 27 (79%) were on antidepressant medication at the time they were referred
for hospice care. More than one-third of the
participants met the criteria for depression
on at least one study visit (Table 2). The prevalence of depression remained relatively constant across the span of study enrollment
(Table 3). Fourteen individuals were depressed
at first study visit, whereas 16 developed a new
episode of depression after the initial study
visit. Half (15 out of 30) of the patients who
developed major depression during hospice
enrollment had no previous history of depression. Depression during hospice was unrelated
to any demographic grouping or hospicequalifying diagnosis.

Suicidal Ideation
SI was acknowledged over the course of
the study by 12 (14%) participants. On the
visit date that SI was endorsed, half also reported sleep disturbance, and 58% met our
depression criteria (Table 4). Four of the 12

Anxiety
Over the course of study participation, 16%
of the participants experienced substantial
anxiety (Table 2), with point prevalence at
entry of 7% and of last visit at or less than
3% (Table 3). Experience of depression during hospice was associated with greater likelihood that anxiety (P ¼ 0.01) would develop
at any point in the study.
Table 4
Concurrent Neuropsychiatric Disorders Among
Patients Who Indicated SI (n ¼ 12)
Disorder
Depressiona,b
Anxietya,c
Sleep disturbanced
Alcohol abusea,e

n(%)
7
4/8
6
1

(58.3)
(50)
(50.0)
(8.3)

a
Coded as not present when patient was delirious (CAM) is
positive.
b
Based on positive SCID or HADS depression $ 11.
c
HADS anxiety score $ 10.
d
Based on CAM item, ‘‘Did the patient have evidence of disturbance of the sleep-wake cycle, such as excessive daytime sleepiness
with insomnia at night?’’
e
SCID screening question for current alcohol abuse.
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Alcohol Abuse
In structured interview, more than 45% of
the participants met the criteria for history of
alcohol abuse or dependence (Table 1), and
10% abused alcohol at some point during
hospice enrollment. Four continued to abuse
alcohol until the final study visit (Table 3);
only one new case of alcohol abuse occurred
after hospice enrollment.

Discussion
The main finding of our study is that
community-dwelling veteran hospice patients
experience a sizable burden of neuropsychiatric
syndromes during the final months of life; in this
study, 88% of the participants were diagnosed
with at least one neuropsychiatric syndrome during the course of hospice care. This longitudinal
study also demonstrates that psychiatric distress
mounts as the final weeks of life approach.
Across the median three months of hospice
care delivered to our participants, the likelihood
of having any of the measured problems rose
from more than half at first visit to more than
three-quarters at last visit, with significant increases in the prevalence of delirium, cognitive
impairment, and sleep disturbance close to the
end of life. Clearly, psychosocial and psychiatric
issues should be a high priority when assessing
for palliative needs at the end of life.
Studies set in inpatient palliative cancer
units that use rigorous criteria report that the
prevalence of major depressive disorder is between 9% and 14%,3,5 and one with a mixed
population of inpatients and home-care palliative cancer patients found major depressive
disorder in 21%.8 Our measures of point prevalence at first (19%) and last (15%) study visits
were comparable. Although the prevalence of
depression appears relatively stable across the
span of hospice enrollment, more than half
(16 out of 30) of the veterans who did not
have depression at first study visit subsequently
developed depression. Our longitudinal design revealed that over the course of hospice
enrollment, an individual has nearly a one-inthree chance of experiencing a depressive episode. This suggests that ongoing surveillance
for depression is necessary for optimal treatment; simply screening on hospice admission
will not suffice.
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Interestingly, a lifetime history of depression
did not necessarily predict a depressive episode during hospice enrollment. In contrast,
Akechi et al. demonstrated a relationship between past and current depression in terminally ill Japanese cancer patients.6 We found
that 79% of individuals with a history of depression entered hospice on an antidepressant medication. It seems likely that medication and
possible psychosocial support linked to recognition and treatment of depression reduced their
vulnerability for subsequent episodes. Health
care providers should be aware that most of
those who succumb to depression at the very
end of life have had a life history of relative resilience that cannot necessarily be sustained
through the challenges of the dying process.
Not surprisingly, the prevalence of delirium
and sleep disturbance rose significantly from
the first to the last visit. A Taiwanese study of
delirium presence in terminal cancer inpatients reported a prevalence of 47%, very similar to our overall finding that 54.5% ever
experienced delirium during the course of
the study, although other inpatient studies report prevalence greater than 90%.7 However,
at entry, only 4.1% of our participants were assessed as delirious. Studies of inpatient populations may reflect circumstances most
comparable with those experienced by our
community participants at the end of the
study, in the final weeks of life. However, our
monitoring may have missed some delirious
episodes in the one- to two-week span between
study visits. At a minimum, informing family
members that delirium and sleep disturbance
increase significantly over entry to hospice
may help them feel better prepared.
SI was found in 12% of our sample, based on
the SCID single item, but seven of the 12 with
SI also were rated as depressed at the same
study visit. Kelly et al. measured interest in hastening death in terminally ill cancer patients,
using a six-item questionnaire, and reported
that 14% of the respondents had high levels
of wish to hasten death.13 Despite differences
in measures and populations, these findings
suggest that about one in 10 hospice patients
wish for death to be hastened.
The hospice trajectory might place people at
risk of turning or returning to alcohol abuse as
a means of coping, particularly as they lose access to other hobbies and activities that may
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have enhanced coping; however, this was not
the case in our study. The prevalence remained at 10% overall, and only one new patient relapsed into alcohol abuse by the final
visit. On the other hand, our study found
that some patients who abused alcohol on
admission were not likely to stop before the
final study visit. More work is needed to increase our understanding of the impact of
alcohol abuse on treatments and quality of
life in hospice; access to substance abuse treatment services in hospice; and views of hospice
providers toward alcohol abuse in this
population.
There are many difficulties inherent in
studying palliative care and hospice populations, and this study has related limitations.
Our participation proportion of 33% reflects
that it is difficult to represent the dying population in research when the most debilitated
patients often feel too ill to participate. Although systematic reviews of research on advanced disease10 critique the literature based
on poor participation rates, it is questionable
whether longitudinal studies in hospice care
are able to meet standards of recruitment
necessary to assure confidence in generalizability.14 Recruitment for this study certainly
reflected that the most moribund were less
likely to participate. We intentionally included
diseases other than cancer to represent a typical hospice roster; however, the heterogeneity
of illnesses and varying length of enrollment
across subjects prevented us from systematically examining comorbidities. Other limitations include that the population was a
veteran, mostly male, Caucasian group from
the northwest United States, and the overall
number of study participants was small. Our
veterans may enter hospice earlier than other
groups as they have the option of continuing
to receive VA and hospice care.
In conclusion, the final months of life are
complicated by increasing burden of neuropsychiatric syndromes for the vast majority of
community-dwelling veteran hospice patients.
Care plans in hospices should include periodic
reassessment for new-onset depression and SI,
and knowledge that delirium and sleep disturbance accelerate in the final weeks may help
family members be better prepared to cope
with their loved one’s experience at the end
of life.
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